Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Arca biopharma, a biopharmaceutical company, has appointed Kathryn Falberg, formerly CFO of Amgen, as its new CFO and COO.
Subscribe to our email newsletter
As Arca’s CFO and COO, Ms Falberg will be responsible for the company’s accounting, corporate finance, financial planning, treasury and other corporate functions. Ms Falberg will report to Richard Brewer, president and CEO of Arca.
Ms Falberg joins Arca from Canyon Capital & Consulting, an investment and consulting firm where she served as president since 2003. Ms Falberg has received an MBA and BA in economics from the University of California, Los Angeles.
Mr Brewer said: “We are delighted to be able to attract an experienced executive of Kate’s caliber at this exciting time in Arca’s development. Kate has a proven track record of overseeing corporate decision making across all the functional areas of growing public companies. With her strong financial and operational experience in the biotech and life sciences industries, we believe Kate will be an excellent addition to the Arca team.”